The startup manufactures critical injectable medications for use in acute care hospitals, outpatient clinics, and physician offices, utilizing precise formulation and aseptic processing techniques. This addresses the need for reliable access to essential treatments for patients with various medical conditions.
Funding
$26M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare facilities require a consistent and reliable supply of essential injectable medications to treat patients in various acute and outpatient settings. Disruptions in the supply chain or inconsistencies in medication quality can compromise patient care and safety.
Solution
Avenacy is a specialty pharmaceutical company that focuses on providing high-quality, FDA-approved injectable medications. The company is building a resilient portfolio of products through a rigorous selection process and a diverse global network of development and manufacturing partners. Avenacy's product offerings are designed to enhance safety and streamline efficiency, with proprietary labeling to assist pharmacists in accurate medication selection and reduce the risk of administration errors. By focusing on quality, safety, and reliability, Avenacy aims to be a trusted partner for healthcare providers, ensuring access to critical medications that support better patient outcomes.
Target Audience
Avenacy serves acute care hospitals, outpatient clinics, and physician offices that require a reliable supply of essential injectable medications.
Features
- Portfolio of FDA-approved sterile injectable medications
- Proprietary label designs for accurate medication selection
- Focus on quality assurance and regulatory affairs
- Diverse global network of development and manufacturing partners
- Supply chain designed for resilience